Ramya Vallabhaneni is an associate in the New York office of Latham & Watkins.
Ramya advises clients on patent and trade secret litigation, particularly in the life sciences and biotechnology industries. She has experience representing clients in cases involving medical devices, antibody discovery, and content delivery.
Prior to joining Latham, Ramya was an associate at a leading US law firm. While in law school, Ramya served as an editor for the Boston College International & Comparative Law Review. While in law school, Ramya also externed at the United Nations International Criminal Tribunal for the Former Yugoslavia.
Ramya maintains an active pro bono practice, representing individuals in immigration matters, including those seeking asylum.
Two Latham litigation teams recognized for securing a rare preliminary injunction in biosimilar patent litigation for J&J’s Jassen and a first-round dismissal with prejudice of a securities class action on behalf of VinFast.
A Latham team led by David Frazier won the “Litigators of the Week” competition, alongside co-counsel at Covington, for their outstanding representation of AbbVie in securing the latest of five patent litigation settlements with generic makers that are set to protect its blockbuster immunology drug Rinvoq until 2037.
Latham's Intellectual Property Litigation Practice was honored for securing exceptional trial results this year, including a complete jury trial win for Sarepta Therapeutics and an ITC trial win for Netgear.